References
- Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008;83:489–501
- Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467–75
- Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr. Accessed
- Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300
- Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 2010;15:994–1001
- Gold KA, Lee HY, Kim ES. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009;115:922–35
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: head and neck cancers. V.2. 2010. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed November 4, 2010
- Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008;359:1116–27
- Menzin J, Lines LM, Manning LN. The economics of squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2007;15:68–73
- Lee JM, Turini M, Botteman MF, et al. Economic burden of head and neck cancer: a literature review. Eur J Health Econ 2004;5:70–80
- Lang K, Menzin J, Earle CC, et al. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg 2004;130:1269–75
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epi 1992;45:613–9
- Murphy BA, Beaumont JL, Isitt J, et al. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manage 2009;38:522–32
- Epstein JD, Knight TK, Epstein JB, et al. Cost of care for early- and late-stage oral and pharyngeal cancer in the California Medicaid population. Head Neck 2008;30:178–86
- Peterman A, Cella D, Glandon G, et al. Mucositis in head and neck cancer: economic and quality-of-life outcomes. J Natl Cancer Inst Monogr 2001;29:45–51
- Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the Cost of Cancer Care in the U.S.: 2010-2020. J Natl Cancer Inst 2011;103:117–28